Chiglitazar Added to Metformin for Type 2 Diabetes
Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to evaluate the effect of Chiglitazar added to metformin to type
2 diabetes Inadequately controlled with metformin Monotherapy.